Nimer Assy
Nimer Assy is an expert in Gastroenterology at Galilee Medical Center (Israel). Nimer Assy has authored 132 publications, the most recent in 2026, and is an investigator in 23 clinical trials. SLR score: 713 (community average: 125). How the SLR is computed.
LeadR Profile
Gastroenterology
Subspecialties: Hepatology - Nephrology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 132
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Renal Impairment as an Independent Predictor of Sepsis in Cirrhosis: A Retrospective Cohort Study. PMID 42075180 — creatinine, mortality, laboratories, serum, liver cirrhosis, cohort studies, liver, sepsis, sex, varicose veins | Microorganisms | 2026 | 0 |
| Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial. PMID 41196655 — kidney diseases, creatinine, albuminuria, kidney, nephrology | J Am Soc Nephrol | 2025 | 0 |
| Multiorgan fibrosis in Gaucher disease type I: an unmet goal of enzyme replacement therapy. PMID 40876511 — fibrosis, liver, enzymes, enzyme replacement therapy, therapeutics, gastrointestinal diseases, gaucher disease, spleen, cytopenia | Clin Res Hepatol Gastroenterol | 2025 | 0 |
| Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. PMID 40470996 — diabetes mellitus, kidney diseases, creatinine, kidney, therapeutics, diabetes mellitus, type 2 | N Engl J Med Top journal | 2025 | 7 |
| Hidden in the Fat: Unpacking the Metabolic Tango Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Syndrome. PMID 40244398 — liver diseases, multiple chronic conditions, liver, biomarkers, precision medicine, research, therapeutics, metabolic syndrome | Int J Mol Sci | 2025 | 0 |
Clinical Studies 23
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map